Neurocrine Acquiring Soleno Therapeutics for $2.9B: Employee Rights - Samfiru Tumarkin LLP
Is Soleno Therapeutics Being Acquired? Yes — Neurocrine Biosciences has entered into a “definitive agreement” to acquire Soleno Therapeutics in a deal valued at approximately $2.9 billion. Through...
Read more